Literature DB >> 27378229

Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas.

Yun-Hee Choi1, Laurent Briollais2, Aung K Win3, John Hopper3, Dan Buchanan3, Mark Jenkins3, Lajmi Lakhal-Chaieb4.   

Abstract

In this article, we propose an association model to estimate the penetrance (risk) of successive cancers in the presence of competing risks. The association between the successive events is modeled via a copula and a proportional hazards model is specified for each competing event. This work is motivated by the analysis of successive cancers for people with Lynch Syndrome in the presence of competing risks. The proposed inference procedure is adapted to handle missing genetic covariates and selection bias, induced by the data collection protocol of the data at hand. The performance of the proposed estimation procedure is evaluated by simulations and its use is illustrated with data from the Colon Cancer Family Registry (Colon CFR).
© 2016, The International Biometric Society.

Entities:  

Keywords:  Ascertainment correction; Missing covariates; Penetrance function; Successive competing risks

Mesh:

Year:  2016        PMID: 27378229      PMCID: PMC5319907          DOI: 10.1111/biom.12561

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  14 in total

1.  A semiparametric random effects model for multivariate competing risks data.

Authors:  Thomas H Scheike; Yanqing Sun; Mei-Jie Zhang; Tina Kold Jensen
Journal:  Biometrika       Date:  2010-03       Impact factor: 2.445

2.  Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

Authors:  Heather Hampel; Julie A Stephens; Eero Pukkala; Risto Sankila; Lauri A Aaltonen; Jukka-Pekka Mecklin; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

3.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.

Authors:  Susan Parry; Aung Ko Win; Bryan Parry; Finlay A Macrae; Lyle C Gurrin; James M Church; John A Baron; Graham G Giles; Barbara A Leggett; Ingrid Winship; Lara Lipton; Graeme P Young; Joanne P Young; Caroline J Lodge; Melissa C Southey; Polly A Newcomb; Loïc Le Marchand; Robert W Haile; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins
Journal:  Gut       Date:  2010-12-30       Impact factor: 23.059

4.  Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.

Authors:  Mark A Jenkins; James G Dowty; Driss Ait Ouakrim; John D Mathews; John L Hopper; Youenn Drouet; Christine Lasset; Valérie Bonadona; Aung Ko Win
Journal:  J Clin Oncol       Date:  2014-12-22       Impact factor: 44.544

Review 5.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

6.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

7.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

8.  Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO.

Authors:  Hormuzd A Katki; Amanda Blackford; Sining Chen; Giovanni Parmigiani
Journal:  Stat Med       Date:  2008-09-30       Impact factor: 2.373

Review 9.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

Authors:  H T Lynch; P M Lynch; S J Lanspa; C L Snyder; J F Lynch; C R Boland
Journal:  Clin Genet       Date:  2009-07       Impact factor: 4.438

10.  Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model.

Authors:  Yun-Hee Choi; Laurent Briollais; Jane Green; Patrick Parfrey; Karen Kopciuk
Journal:  Stat Med       Date:  2013-08-15       Impact factor: 2.373

View more
  1 in total

1.  A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families.

Authors:  Yun-Hee Choi; Hae Jung; Saundra Buys; Mary Daly; Esther M John; John Hopper; Irene Andrulis; Mary Beth Terry; Laurent Briollais
Journal:  Stat Methods Med Res       Date:  2021-07-07       Impact factor: 3.021

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.